Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Consistent stronger volume

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon Dec 18, 2020 4:28pm

135 Views

Post# 32142435

RE:RE:Consistent stronger volume

wofats wrote: More than 10% of the total shares traded this week
Unusual

9,500,549 today.

Insider buying ... all going into Management friendly hands.
That's exactly as expected.
Offer cheap shares and they will be sucked up by Goodman, company and friends.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”